(Medical College of Georgia at Augusta University) An experimental compound appears to improve stroke outcome by reducing the destructive inflammation that can continue months after a stroke, scientists report.Rats consuming compound 21 following a clot-based stroke -- the most common type in humans -- don't have a smaller stroke size but do have better memory and movement in its aftermath, says Dr. Adviye Ergul, vascular physiologist and Regents' Professor in the Department of Physiology at the Medical College of Georgia at Augusta University.
Original Article: Compound improves stroke outcome by reducing lingering inflammation